Meilin Liao
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 2%
- Cancer Research top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Co-authors
- Maya GottfriedJoachim von PawelJosé BarruecoBirgit Gaschler‐MarkefskiAnders MellemgaardMaciej KrzakowskiIgor BondarenkoR. Kaiser
- Topics
- Lung Cancer Treatments and Mutations (29 papers)Lung Cancer Diagnosis and Treatment (15 papers)Lung Cancer Research Studies (11 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Lancet Oncology
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Meilin Liao
44 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 1.6k
- Oncology 1.3k
- Cancer Research 580
- Molecular Biology 571
- Pathology and Forensic Medicine 176
Countries citing papers authored by Meilin Liao
This map shows the geographic impact of Meilin Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilin Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilin Liao more than expected).
Fields of papers citing papers by Meilin Liao
This network shows the impact of papers produced by Meilin Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilin Liao. The network helps show where Meilin Liao may publish in the future.
Co-authorship network of co-authors of Meilin Liao
This figure shows the co-authorship network connecting the top 25 collaborators of Meilin Liao. A scholar is included among the top collaborators of Meilin Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meilin Liao. Meilin Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapybreakdown → | 367 |
| 3 | 40 | |
| 4 | Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trialbreakdown → | 694 |
| 5 | 22 | |
| 6 | 5 | |
| 7 | 27 | |
| 8 | 38 | |
| 9 | 17 | |
| 10 | 38 | |
| 11 | 36 | |
| 12 | 19 | |
| 13 | 5 | |
| 14 | 1 | |
| 15 | Effect of thymosin α1 for advanced non-small-cell lung cancer in chemotherapy patients | 1 |
| 16 | [The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer]. | 3 |
| 17 | 1 | |
| 18 | 51 | |
| 19 | Homozygous deletion of p16 gene in non-small cell lung cancer | 1 |
| 20 | 23 |
About Meilin Liao
Meilin Liao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Lung Cancer Research Studies (11 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Cancer Research (580 citations). Meilin Liao has collaborated with scholars based in China, United States and France. Frequent co-authors include Maya Gottfried, Joachim von Pawel, José Barrueco, Birgit Gaschler‐Markefski, Anders Mellemgaard, Maciej Krzakowski, Igor Bondarenko, R. Kaiser, Silvia Novello and Martin Reck. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.